Saccharomyces cerevisiae adapted to grow in the presence of low-dose rapamycin exhibit altered amino acid metabolism
Abstract Background Rapamycin is a potent inhibitor of the highly conserved TOR kinase, the nutrient-sensitive controller of growth and aging. It has been utilised as a chemotherapeutic agent due to its anti-proliferative properties and as an immunosuppressive drug, and is also known to extend lifes...
Main Authors: | Duygu Dikicioglu, Elif Dereli Eke, Serpil Eraslan, Stephen G. Oliver, Betul Kirdar |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-11-01
|
Series: | Cell Communication and Signaling |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12964-018-0298-y |
Similar Items
-
The Plant Target of Rapamycin: A Conduc TOR of Nutrition and Metabolism in Photosynthetic Organisms
by: Camille Ingargiola, et al.
Published: (2020-10-01) -
Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells
by: Zoltán Hujber, et al.
Published: (2017-06-01) -
Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells
by: Gábor Petővári, et al.
Published: (2018-12-01) -
The TOR Signaling Network in the Model Unicellular Green Alga Chlamydomonas reinhardtii
by: María Esther Pérez-Pérez, et al.
Published: (2017-07-01) -
Rapamycin Inhibits Expansion of Cord Blood Derived NK and T Cell
by: Monireh Zare, et al.
Published: (2017-09-01)